A pharmaco-metabolomics approach in a clinical trial of ALS: Identification of predictive markers of progression

There is an urgent and unmet need for accurate biomarkers in Amyotrophic Lateral Sclerosis. A pharmaco-metabolomics study was conducted using plasma samples from the TRO19622 (olesoxime) trial to assess the link between early metabolomic profiles and clinical outcomes. Patients included in this tria...

Descripción completa

Detalles Bibliográficos
Autores principales: Blasco, Hélène, Patin, Franck, Descat, Amandine, Garçon, Guillaume, Corcia, Philippe, Gelé, Patrick, Lenglet, Timothée, Bede, Peter, Meininger, Vincent, Devos, David, Gossens, Jean François, Pradat, Pierre-François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5988280/
https://www.ncbi.nlm.nih.gov/pubmed/29870556
http://dx.doi.org/10.1371/journal.pone.0198116

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5988280/
https://www.ncbi.nlm.nih.gov/pubmed/29870556
http://dx.doi.org/10.1371/journal.pone.0198116

Ejemplares similares